VMI
RGNX icon

VHCP Management II’s Regenxbio RGNX Stock Holding History

VHCP Management II’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-332,494
Closed -$4.66M – 24
2016
Q3 		$4.66M Sell
332,494
-667,139
-67% -$7.36M 2.39% 11
2016
Q2 		$8M Sell
999,633
-31,321
-3% -$348K 4.83% 6
2016
Q1 		$11.1M Hold
1,030,954
– – 7.32% 6
2015
Q4 		$15.9M Buy
+1,030,954
New +$20.5M 13.04% 2

Other funds holding RGNX

BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

VHCP Management II's RGNX Position: Q4 2016 in Review

VHCP Management II sold out of Regenxbio (RGNX) in Q4 2016, closing a stake of 332,494 shares — an estimated $4.66M sold.

VHCP Management II first reported a position in RGNX in Q4 2015 and held it in 4 quarters. The position peaked at $15.9M in Q4 2015. 78 funds tracked by Wall St. Rank hold RGNX as of Q4 2016.

  • VHCP Management II reported no remaining Regenxbio position as of Q4 2016 after selling out during the quarter.
  • VHCP Management II sold 332,494 Regenxbio shares in Q4 2016, an estimated $4.66M.
  • VHCP Management II first reported a position in Regenxbio in Q4 2015 and held it in 4 quarters.
  • VHCP Management II's Regenxbio position peaked at $15.9M in Q4 2015.
  • 78 funds tracked by Wall St. Rank held Regenxbio as of Q4 2016.

Based on VHCP Management II's 13F filing for Q4 2016, filed 13 Feb 2017.